IOL CHEMICALS & PHARM. | PANACEA BIOTECH | IOL CHEMICALS & PHARM./ PANACEA BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | -70.0 | - | View Chart |
P/BV | x | 1.5 | 1.0 | 152.1% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PANACEA BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PANACEA BIOTECH Mar-23 |
IOL CHEMICALS & PHARM./ PANACEA BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 191 | 280.5% | |
Low | Rs | 272 | 107 | 254.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 75.1 | 502.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | -5.5 | -430.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.9 | 3,594.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 137.7 | 186.5% | |
Shares outstanding (eoy) | m | 58.71 | 61.25 | 95.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.0 | 53.9% | |
Avg P/E ratio | x | 17.1 | -27.1 | -63.0% | |
P/CF ratio (eoy) | x | 12.8 | 170.0 | 7.5% | |
Price / Book Value ratio | x | 1.6 | 1.1 | 145.3% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 9,142 | 259.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,265 | 133.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 4,599 | 482.0% | |
Other income | Rs m | 256 | 517 | 49.6% | |
Total revenues | Rs m | 22,427 | 5,116 | 438.4% | |
Gross profit | Rs m | 2,257 | 47 | 4,799.4% | |
Depreciation | Rs m | 462 | 391 | 118.0% | |
Interest | Rs m | 165 | 44 | 371.2% | |
Profit before tax | Rs m | 1,887 | 128 | 1,473.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 466 | 106.4% | |
Profit after tax | Rs m | 1,391 | -337 | -412.3% | |
Gross profit margin | % | 10.2 | 1.0 | 995.7% | |
Effective tax rate | % | 26.2 | 363.5 | 7.2% | |
Net profit margin | % | 6.3 | -7.3 | -85.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 5,623 | 171.9% | |
Current liabilities | Rs m | 5,025 | 3,297 | 152.4% | |
Net working cap to sales | % | 20.9 | 50.6 | 41.4% | |
Current ratio | x | 1.9 | 1.7 | 112.8% | |
Inventory Days | Days | 43 | 59 | 73.7% | |
Debtors Days | Days | 8 | 48 | 17.4% | |
Net fixed assets | Rs m | 11,017 | 7,028 | 156.8% | |
Share capital | Rs m | 587 | 61 | 958.5% | |
"Free" reserves | Rs m | 14,490 | 8,375 | 173.0% | |
Net worth | Rs m | 15,077 | 8,436 | 178.7% | |
Long term debt | Rs m | 0 | 202 | 0.0% | |
Total assets | Rs m | 20,684 | 12,712 | 162.7% | |
Interest coverage | x | 12.5 | 3.9 | 320.5% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 296.2% | |
Return on assets | % | 7.5 | -2.3 | -326.3% | |
Return on equity | % | 9.2 | -4.0 | -230.7% | |
Return on capital | % | 13.6 | 2.0 | 681.5% | |
Exports to sales | % | 26.7 | 43.3 | 61.8% | |
Imports to sales | % | 0 | 24.4 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 1,992 | 297.7% | |
Imports (cif) | Rs m | NA | 1,124 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,992 | 297.7% | |
Fx outflow | Rs m | 6,052 | 1,191 | 508.2% | |
Net fx | Rs m | -122 | 801 | -15.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -4,225 | -28.9% | |
From Investments | Rs m | -1,200 | 4,303 | -27.9% | |
From Financial Activity | Rs m | -41 | -184 | 22.4% | |
Net Cashflow | Rs m | -18 | -105 | 17.5% |
Indian Promoters | % | 48.2 | 73.6 | 65.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.1 | 153.2% | |
FIIs | % | 1.4 | 0.3 | 518.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 26.4 | 196.2% | |
Shareholders | 130,003 | 46,242 | 281.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Panacea Biotech | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.96% | 0.04% | 0.09% |
1-Month | 9.28% | 1.75% | 2.42% |
1-Year | -0.25% | 14.98% | 52.88% |
3-Year CAGR | -11.22% | -19.55% | 14.89% |
5-Year CAGR | 15.70% | -7.14% | 19.33% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Panacea Biotech share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Panacea Biotech.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Panacea Biotech.
For a sector overview, read our pharmaceuticals sector report.
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.